天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 402960-38-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 402960-38-7
Chemical Structure| 402960-38-7
Structure of 402960-38-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 402960-38-7 ]

Related Doc. of [ 402960-38-7 ]

Alternatived Products of [ 402960-38-7 ]
Product Citations

Product Details of [ 402960-38-7 ]

CAS No. :402960-38-7 MDL No. :MFCD06795685
Formula : C10H16BN3O2 Boiling Point : No data available
Linear Structure Formula :- InChI Key :BPQVMIDUTRJYSC-UHFFFAOYSA-N
M.W : 221.06 Pubchem ID :17750212
Synonyms :

Calculated chemistry of [ 402960-38-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.6
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 62.91
TPSA : 70.26 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 0.84
Log Po/w (WLOGP) : 0.37
Log Po/w (MLOGP) : -0.31
Log Po/w (SILICOS-IT) : 0.06
Consensus Log Po/w : 0.19

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.95
Solubility : 2.47 mg/ml ; 0.0112 mol/l
Class : Very soluble
Log S (Ali) : -1.9
Solubility : 2.79 mg/ml ; 0.0126 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.9
Solubility : 0.278 mg/ml ; 0.00126 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.83

Safety of [ 402960-38-7 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 402960-38-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 402960-38-7 ]
  • Downstream synthetic route of [ 402960-38-7 ]

[ 402960-38-7 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 402960-38-7 ]
  • [ 1032757-58-6 ]
  • [ 1032754-93-0 ]
YieldReaction ConditionsOperation in experiment
10 mg With bis-triphenylphosphine-palladium(II) chloride In acetonitrile The Suzuki-type coupling reaction is useful to attach a monocyclic heteroaryl at the 2-position of the pyrimidine ring (see Scheme 4). Generally, substituted 2-chloro-4-morpholinothieno[3,2-d]pyrimidine 5 or substituted 2-chloro-4-morpholinothieno[2,3-d]pyrimidine 6 may be combined with 1.5 equivalents of 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine 7a, and dissolved in 3 equivalents of sodium or potassium carbonate as a 1 molar solution in water and an equal volume of acetonitrile. A catalytic amount, or more, of a low valent palladium reagent, such as bis(triphenylphosphine)palladium(II) dichloride, is added. A variety of boronic acids or boronic esters can be used in place of the pinacol boronic ester indicated. Also alternatively, the nitrogen of the pyrimidin-2-amine may be protected, for example with a tetrahydropyranyl group. In some cases potassium acetate was used in place of sodium carbonate to adjust the pH of the aqueous layer. The reaction was then heated, for example to about 100-150° C. under pressure in a Biotage Optimizer microwave reactor (Biotage, Inc.) for 10 to 30 minutes. The contents are extracted with ethyl acetate, or another organic solvent. After evaporation of the organic layer the product, 8a or 9a, may be purified on silica or by reverse phase HPLC. (S)-1-(4-((2-Chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one (60 mg) was reacted with 50 mg of 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine via General Procedure A-2 to give 10 mg of Formula Ib (WO 2008/070740, incorporated by reference).
Reference: [1] Patent: JP5658565, 2015, B2, . Location in patent: Paragraph 0286; 0366; 0369
  • 2
  • [ 402960-38-7 ]
  • [ 1382980-58-6 ]
  • [ 1382979-44-3 ]
YieldReaction ConditionsOperation in experiment
27% With caesium carbonate In 1,2-dimethoxyethane; water at 140℃; for 0.333333 h; Microwave irradiation; Inert atmosphere Step 3: 2-Chloro-6,6-dimethyl-4-morpholino-8,9-dihydro-6H-[l,4]oxazino[3,4- e]purine (180 mg, 0.56 mmol) in 1 ,2-dimethoxyethane (5.1 mL) was added 5-(4,4,5,5- tetramethyl-l,3,2-dioxaborolan-2-yl)pyrimidin-2-amine 25 (180 mg, 0.83 mmol) and 1.0 M of cesium carbonate in water (1.7 mL). The reaction mixture was degassed for 5 min and recycled with nitrogen atmosphere. Subsequently, l, -bis(diphenylphosphino)ferrocenepalladium(II) chloride (54 mg, 0.067 mmol) was added, and the mixture was degassed and recycled again. The reaction vial was then subjected to microwave irradiation for 20 mins at 140 °C. Solid precipitate that formed during the reaction was filtered and rinsed with excess water. The precipitate was taken up in DCM and purified by FCC (40 g, 0.5-4percent MeOH in DCM, slow gradient) to isolate103 as a tan powder (56 mg, 27percent yield). MS (ESI+): m/z 383.1 (M+H+). 1H NMR (400 MHz, DMSO) δ 9.09 (s, 2H), 7.00 (s, 2H), 4.23 (m, 4H), 4.13 (m, 4H), 3.79 - 3.68 (m, 4H), 2.50 (s, 6H)
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 4, p. 751 - 759
[2] Patent: WO2012/82997, 2012, A1, . Location in patent: Page/Page column 91
[3] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 4, p. 351 - 356
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 402960-38-7 ]

Organoboron

Chemical Structure| 321724-19-0

[ 321724-19-0 ]

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

Similarity: 0.92

Chemical Structure| 1218791-44-6

[ 1218791-44-6 ]

N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.89

Chemical Structure| 944401-55-2

[ 944401-55-2 ]

4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.89

Chemical Structure| 1218791-46-8

[ 1218791-46-8 ]

N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.87

Chemical Structure| 1052686-67-5

[ 1052686-67-5 ]

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

Similarity: 0.84

Amines

Chemical Structure| 1218791-44-6

[ 1218791-44-6 ]

N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.89

Chemical Structure| 944401-55-2

[ 944401-55-2 ]

4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.89

Chemical Structure| 1218791-46-8

[ 1218791-46-8 ]

N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.87

Chemical Structure| 944401-58-5

[ 944401-58-5 ]

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine

Similarity: 0.77

Chemical Structure| 936250-22-5

[ 936250-22-5 ]

(2-Aminopyrimidin-5-yl)boronic acid

Similarity: 0.73

Related Parent Nucleus of
[ 402960-38-7 ]

Pyrimidines

Chemical Structure| 321724-19-0

[ 321724-19-0 ]

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

Similarity: 0.92

Chemical Structure| 1218791-44-6

[ 1218791-44-6 ]

N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.89

Chemical Structure| 944401-55-2

[ 944401-55-2 ]

4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.89

Chemical Structure| 1218791-46-8

[ 1218791-46-8 ]

N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

Similarity: 0.87

Chemical Structure| 1052686-67-5

[ 1052686-67-5 ]

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

Similarity: 0.84

; ;